Wednesday, December 20, 2006

Forest drug tops Lilly's in depression trial



Reuters - Eli Lilly and Co.'s (LLY.N: Quote , Profile , Research ) newer antidepressant Cymbalta in treating moderate to severe depression of patients who received Lexapro reached the improvement goal compared to 52 percent who responded to treatment with
Source: today.reuters.com

Remission Possible, But Hard to Sustain
Psychiatric News - We found that patients with more severe depression, greater general medical or psychiatric comorbidity, and chronicity made up the group that needed more treatment steps" to reach follow-up—either by achieving remission or at least a meaningful
Source: pn.psychiatryonline.org

Penn psychiatrist to be honored today
Philadelphia Inquirer - of cognitive therapy "is one of the most important advances - if not the most important advance - in the treatment" of General Psychiatry reported that cognitive therapy could be as effective as medications in treating moderate to severe depression
Source: www.philly.com

Meth plea nets probation
Journal Gazette and Times Courier - Terms of his sentence included six months in jail, but he’ll be released if he can get into residential drug treatment IF I can get through the Christmas Season without any severe depression I'll try kicking the habit again. That sounds like the
Source: www.jg-tc.com


Click here for more information about manic depression manic depression